Preclinical strategies for precision medicine in colorectal cancer
4 Jul 2016
Preclinical strategies for precision medicine in colorectal cancer
Personalising breast cancer therapy
Characterisation of somatic mutations using patient RNASeq profiles
WIN 2016 highlights: Changing the understanding of cancer
Systems thinking in the future of personalised medicine
Precision cancer medicine in Korea
New targets in personalised therapy for patients with lung cancer
A global perspective on infections related to cancer
MetAL trial for prostate cancer
Modelling ponatinib resistance in BCR-ABL1 cell lines
Genomic interrogation of tumour samples reveals essential targets
Breast and cervical cancer rates influenced by HRT, not contraceptive pill